Practice Tools

Practical resources to support your canine OA patients

Our library is designed to connect you with the latest insight, medical tools, educational opportunities and activities to support the veterinary profession in managing canine osteoarthritis (OA) and implementing the effective use of Adequan® Canine (polysulfated glycosaminoglycan). Take a look at the links below and choose what best fits your search for information.

Clinical Studies Canine red ball dog

Journal Article: Validity of COAST Staging Tool

To support early intervention with OA diagnosis and management, a group of veterinary experts collaborated to create the Canine OsteoArthritis Staging Tool (COAST). Learn more about the science behind the COAST tool and its potential benefits in The Veterinary Journal article "Face validity of a proposed tool for staging canine osteoarthritis: Canine OsteoArthritis Staging Tool (COAST)."


COAST Article

Technical Bulletin: A Disease-Modifying Osteoarthritis Drug

Adequan® Canine is the only FDA-approved disease-modifying osteoarthritis drug (DMOAD) that inhibits cartilage loss in a dog’s synovial joints.1 This technical bulletin will help you learn more about the unique characteristics of Adequan® Canine and the distinct advantages it may provide in slowing the progression of OA in dogs.


DMOAD Bulletin

1. Adequan® Canine Package Insert, Rev. 1/19.

Canine OsteoArthritis Staging Tool

This tool helps you gather insights to better identify early signs of OA in canine patents, while creating an objective baseline from which to diagnose OA and initiate needed treatment. It’s most effective when used in conjunction with the Client Questionnaire: Assessing Discomfort in Your Dog also available on this page.

For the best interactive experience, save the PDF onto your device.


Printable PDF

Interactive PDF

Client Questionnaire: Assessing Discomfort in Your Dog

Ask clients to complete this questionnaire and bring it to their dog’s next appointment. The questionnaire can help clients better identify the early signs of OA, plus it provides you an easy way to initiate the OA conversation. Use the questionnaire with the Canine OsteoArthritis Staging Tool also available on this page.

For the best interactive experience, save the PDF onto your device.


Printable PDF

Interactive PDF

Adequan® Canine brand of polysulfated glycosaminoglycan (PSGAG)
INDICATIONS Adequan® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.
IMPORTANT SAFETY INFORMATION Adequan® Canine should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Adverse reactions in clinical studies (transient pain at injection site, transient diarrhea, and abnormal bleeding) were mild and self-limiting. In post approval experience, death has been reported in some cases; vomiting, anorexia, depression/lethargy and diarrhea have also been reported. The safe use of PSGAG in breeding, pregnant or lactating dogs has not been evaluated. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see Full Prescribing Information.

Let’s stay in touch.

Be the first to hear about important news and product information!
First, select the one that best describes you.
Then we'll take you to our sign-up page.

CANINE VETERINARY
PROFESSIONAL
DOG OWNER
AMERICAN REGENT ANIMAL HEALTH
About Us Our Brands